Drug Delivery Systems

Committed to drug delivery excellence. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.

banner

Overview

Introducing Drug Delivery Systems

Innovative design, global manufacturing, product development expertise

With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.

At a glance…

  • 3 billion

     

    >3Bn

     

    Prefillable Syringes* (PFS) manufactured per year1

  • 2 billion

    $2Bn

    Yearly revenue (2022)**

  • 7500

    7500    

    Associates globally

  • 8 plants

    8

    Manufacturing plants worldwide

  • Global Headquarters

    Global Headquarters

    in Pont-de-Claix, France

500 card

Products used by more than 500 Pharmaceutical and Biotechnology companies.2

27 of 30

BD customers include 27 of the top 30 pharmaceutical companies in the world.3

70 of 100

~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.4

4000

BD has generated over 4000 patents that are enforced in more than 25 countries.5

Patient Well-Being

We are focusing on patient well-being

There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.

These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.

We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.

Solutions to meet your needs across therapeutic areas

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

needle tech
Needle technologies

BD uses proprietary needle technologies to develop needles that optimize your drug delivery.

Explore BD needle technologies
prefillable
Prefillable syringe systems

Featuring a comprehensive portfolio of innovative prefillable syringe systems, BD offers drug delivery solutions designed to help decrease development risk, improve speed to market, and increase flexibility to meet patients’ needs across a wide range of drug types and therapeutic areas.  

Explore our prefillable syringes
safety shield
Safety and shielding systems

BD Safety & Shielding Systems provide pharmaceutical companies with a wide range of both active and passive manual injection solutions available in 0.5ml, 1ml, and 2.25ml formats, suitable for a variety therapeutic indications. 

Explore our safety and shielding devices
Self Injection
Self-injection systems

BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities and help de-risk combination product development. 

Explore our self-injection systems
Add ons and components
Add ons and components

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

Explore our add ons and components

Trusted Expertise

A history of innovation and market leadership

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

Notes

* PFS containers

** BD Annual report 2022

References

  1. BDM-PS Financial file November 2022, “Actual FY22” Permiter.

  2.  BDM-PS Financial file November 2020, "Actual FY20" Permiter.

  3.  BD Customers compared to Evaluate Pharma ranking FY2019

  4. IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines

  5.  BDM-PS Patents – In force – Worldwide – October 2021. 

Solutions to meet your needs across therapeutic areas

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

needle tech
Needle technologies

BD uses proprietary needle technologies to develop needles that optimize your drug delivery.

Explore our needle technologies
prefillable
Prefillable syringe systems

Featuring a comprehensive portfolio of innovative prefillable syringe systems, BD offers drug delivery solutions designed to help decrease development risk, improve speed to market, and increase flexibility to meet patients’ needs across a wide range of drug types and therapeutic areas.  

Explore our prefillable syringes
safety shield
Safety and shielding systems

BD Safety & Shielding Systems provide pharmaceutical companies with a wide range of both active and passive manual injection solutions available in 0.5ml, 1ml, and 2.25ml formats, suitable for a variety therapeutic indications. 

Explore our safety and shielding devices
Self Injection
Self-injection systems

BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities and help de-risk combination product development. 

Explore our self injection systems
customization options add ons banner
Add ons and components

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

Explore our add ons and components

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

Services and Solutions

Services and Solutions

BD understands the drug development process and objectives at each stage and offers a wide range of services to help develop container/device strategy and life cycle management plan for drugs.

Services
Services

BD Pharmaceutical Services and Solutions are designed to help you achieve your combination product goals, from development to launch.

Explore our services
Partner Path
BD PartnerPath program

BD PartnerPath™ Program aims to support pharmaceutical organizations that value speed to market in combination product development.1

Explore more on BD PartnerPath™ program

Our Capabilities

Capabilities

We’ve built our services and capabilities around a deep understanding of the combination product development process and the key objectives at each stage, from discovery to delivery.

We are committed to partnering for your sustained commercial success.

DDS System Integration
System Integration

Effective system integration can be critical to the success of combination products for pharmaceutical companies.1

Explore our system integration
manufacturing excellence
Manufacturing excellence

We manufacture our solutions with a strict focus on continuously advancing quality, consistency and capacity.

Explore our manufacturing
BDM PS Quality - BD Neopak™ Laboratory
Quality

Quality is the foundation of customer and patient trust; it is at the core of what we do to provide safe, effective products and services. All BD associates are committed to a culture of quality inspired by the customers and patients we serve.

Explore our quality

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

References

  1. Market Research “Challenges with System Integration" [external study], Franklin Lakes, NJ, USA: GLG 2019

Documentation 

biologic

Biologic Drugs

Hospital

Hospital Treatments

vaccines

Vaccines

pharma

Specialty Pharmaceuticals

Resources

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact Sales
Please fill out the form and a sales representive will get in touch with you.
Event Icon
HFES International Symposium 2024

March 26 4:45pm - 6:15pm CDT

Salon C

Hilton Chicago Hotel – Chicago, IL 

Learn more
Event Icon
Drug Delivery Summit 2024 - California

California, USA

February 28 - 29, 2024

DoubleTree Hilton Anaheim Resort

 

 

Learn more
Event Icon
TT LifeSciences US Annual Conference

February 7th, 2024 at 3:05pm EDT

Boston - USA

Learn more
Event Icon
Pharmapack 2024 – Paris Expo

Porte de Versailles

January 24-25, 2024

Hall 7.2 – BD Booth E60

 

 

Learn more
News and Media
  • press release 1
    Sep 13, 2022

    BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency

    BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1

    Learn more

  • Press release 2
    May 18, 2022

    BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore 

    Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.

    Learn more

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact Sales
Please fill out the form and a sales representive will get in touch with you.

Contact Us

Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×